Pirro, Federico
Pirro, Federico
ROMA - Dipartimento di Medicina e chirurgia traslazionale
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
2022 Torres, Tiago; Puig, Luis; Vender, Ron; Yeung, Jensen; Carrascosa, José-Manuel; Piaserico, Stefano; Gisondi, Paolo; Lynde, Charles; Ferreira, Paulo; Bastos, Pedro Mendes; Dauden, Esteban; Leite, Luiz; Valerio, Joana; Del Alcázar-Viladomiu, Elena; Rull, Eva Vilarrasa; Llamas-Velasco, Mar; Pirro, Federico; Messina, Francesco; Bruni, Manfredo; Licata, Gaetano; Ricceri, Federica; Nidegger, Alessia; Hugo, Jan; Mufti, Asfandyar; Daponte, Athina-Ioanna; Teixeira, Laetitia; Balato, Anna; Romanelli, Marco; Prignano, Francesca; Gkalpakiotis, Spyridon; Conrad, Curdin; Lazaridou, Elizabeth; Rompoti, Natalia; Papoutsaki, Marina; Nogueira, Miguel; Chiricozzi, Andrea
Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study
2021 Pirro, F.; Caldarola, G.; Chiricozzi, A.; Burlando, M.; Mariani, M.; Parodi, A.; Peris, K.; De Simone, C.
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy
2021 Zangrilli, A.; Caldarola, G.; Bernardini, N.; Bavetta, M.; Graceffa, D.; Bonifati, C.; Cantoresi, F.; Faleri, S.; Giordano, D.; Mariani, M.; Micheli, A.; Moretta, G.; Pirro, F.; Pagnanelli, G.; Panasiti, V.; Provini, A.; Richetta, A.; Sacchelli, L.; Bianchi, L.; Peris, K.
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study
2021 Esposito, M.; Giunta, A.; Gisondi, P.; Tambone, S.; Rovaris, M.; Manfreda, V.; Pirro, F.; Pellegrini, C.; Fargnoli, M. C.; Bianchi, L.; Peris, K.; Girolomoni, G.
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy
2021 Galluzzo, M.; Caldarola, G.; De Simone, C.; Bernardini, N.; Moretta, G.; Pallotta, S.; Botti, E.; Campione, E.; Pirro, F.; Potenza, C.; Bianchi, L.; Peris, K.
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
2020 Caldarola, G.; Pirro, F.; Di Stefani, A.; Talamonti, M.; Galluzzo, M.; D'Adamio, S.; Magnano, M.; Bernardini, N.; Malagoli, P.; Bardazzi, F.; Potenza, C.; Bianchi, L.; Peris, K.; De Simone, C.
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice
2020 Caldarola, G.; Mariani, M.; Pirro, F.; Nicolotti, N.; Burlando, M.; Calabrese, L.; Parodi, A.; Peris, K.; De Simone, C.
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis
2020 D'Urso, D. F.; Chiricozzi, A.; Pirro, F.; Calabrese, L.; Caldarola, G.; Fossati, B.; Desimone, C.; Peris, K.
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies
2020 Pirro, F.; Caldarola, G.; Chiricozzi, A.; Tambone, S.; Mariani, M.; Calabrese, L.; D'Urso, D. F.; De Simone, C.; Peris, K.
A case of guttate psoriasis during treatment with dupilumab
2019 Gori, N.; Caldarola, G.; Pirro, F.; De Simone, C.; Peris, K.
Multiple paradoxical reactions during ixekizumab therapy
2019 Pirro, F.; Caldarola, G.; De Simone, C.; Moretta, G.; Giovanardi, G.; Peris, K.
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2022 | Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study | Torres, Tiago; Puig, Luis; Vender, Ron; Yeung, Jensen; Carrascosa, José-Manuel; Piaserico, Stefano; Gisondi, Paolo; Lynde, Charles; Ferreira, Paulo; Bastos, Pedro Mendes; Dauden, Esteban; Leite, Luiz; Valerio, Joana; Del Alcázar-Viladomiu, Elena; Rull, Eva Vilarrasa; Llamas-Velasco, Mar; Pirro, Federico; Messina, Francesco; Bruni, Manfredo; Licata, Gaetano; Ricceri, Federica; Nidegger, Alessia; Hugo, Jan; Mufti, Asfandyar; Daponte, Athina-Ioanna; Teixeira, Laetitia; Balato, Anna; Romanelli, Marco; Prignano, Francesca; Gkalpakiotis, Spyridon; Conrad, Curdin; Lazaridou, Elizabeth; Rompoti, Natalia; Papoutsaki, Marina; Nogueira, Miguel; Chiricozzi, Andrea | |
| 1-gen-2021 | Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study | Pirro, F.; Caldarola, G.; Chiricozzi, A.; Burlando, M.; Mariani, M.; Parodi, A.; Peris, K.; De Simone, C. | |
| 1-gen-2021 | Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy | Zangrilli, A.; Caldarola, G.; Bernardini, N.; Bavetta, M.; Graceffa, D.; Bonifati, C.; Cantoresi, F.; Faleri, S.; Giordano, D.; Mariani, M.; Micheli, A.; Moretta, G.; Pirro, F.; Pagnanelli, G.; Panasiti, V.; Provini, A.; Richetta, A.; Sacchelli, L.; Bianchi, L.; Peris, K. | |
| 1-gen-2021 | Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study | Esposito, M.; Giunta, A.; Gisondi, P.; Tambone, S.; Rovaris, M.; Manfreda, V.; Pirro, F.; Pellegrini, C.; Fargnoli, M. C.; Bianchi, L.; Peris, K.; Girolomoni, G. | |
| 1-gen-2021 | Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy | Galluzzo, M.; Caldarola, G.; De Simone, C.; Bernardini, N.; Moretta, G.; Pallotta, S.; Botti, E.; Campione, E.; Pirro, F.; Potenza, C.; Bianchi, L.; Peris, K. | |
| 1-gen-2020 | Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature | Caldarola, G.; Pirro, F.; Di Stefani, A.; Talamonti, M.; Galluzzo, M.; D'Adamio, S.; Magnano, M.; Bernardini, N.; Malagoli, P.; Bardazzi, F.; Potenza, C.; Bianchi, L.; Peris, K.; De Simone, C. | |
| 1-gen-2020 | Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice | Caldarola, G.; Mariani, M.; Pirro, F.; Nicolotti, N.; Burlando, M.; Calabrese, L.; Parodi, A.; Peris, K.; De Simone, C. | |
| 1-gen-2020 | New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis | D'Urso, D. F.; Chiricozzi, A.; Pirro, F.; Calabrese, L.; Caldarola, G.; Fossati, B.; Desimone, C.; Peris, K. | |
| 1-gen-2020 | The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies | Pirro, F.; Caldarola, G.; Chiricozzi, A.; Tambone, S.; Mariani, M.; Calabrese, L.; D'Urso, D. F.; De Simone, C.; Peris, K. | |
| 1-gen-2019 | A case of guttate psoriasis during treatment with dupilumab | Gori, N.; Caldarola, G.; Pirro, F.; De Simone, C.; Peris, K. | |
| 1-gen-2019 | Multiple paradoxical reactions during ixekizumab therapy | Pirro, F.; Caldarola, G.; De Simone, C.; Moretta, G.; Giovanardi, G.; Peris, K. |